Trial intelligence / Profile preview

HUNS001-01 in chronic ischemic stroke

NCT06752720Phase 2Recruiting

Sponsor
Hokkaido University Hospital
Start
Dec 2024
Primary completion
Dec 2025
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of HUNS001-01 in ischemic stroke, sponsored by Hokkaido University Hospital. Started Dec 2024; status: recruiting.

02

Drugs

HUNS001-01
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT06752720.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06752720.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call